DexCom, Inc.

NASDAQ:DXCM

Medical - Devices

Healthcare
$82.52 +1.27%

+$0.90 today

Market cap
$30.78B
Beta
1.44
P/E (TTM)
29.9
EPS (TTM)
$2.42
52W Low $54.11High $89.98

Volume 4.25M

Average 5.43M

DXCM Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

DexCom, Inc.NASDAQ: DXCM

Total Equity · Q2 FY2026 · quarter ended Jun 2026

Total equity broadly unchanged from a year ago

Total equity stood at $2.62B at the end of Q2 FY2026, up 1.9% from a year earlier and down 11.3% from the prior quarter. Over 3 fiscal years it compounded at +8.8% a year.

Context

  • Total equity amounted to 40.6% of total assets at the end of Q2 FY2026, up 5.5 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +1.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.62B-11.3% QoQ
Last fiscal yearDec 2025
$2.75B+30.6% YoY
Year agoJun 2025
$2.57B+1.9% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.9%——
1 year+30.6%——
3-year CAGR+8.8%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
2.75B USD
Year-over-year change
+30.6%
4-year CAGR
+7.7%

Total Equity vs competitors

How DXCM compares with its peers on the latest reported figures

  • DXCM's Jun 2026 total equity of $2.62B is the 2nd highest of the 7 companies compared; the peer median is $201.82M.
  • Its year-over-year change of +1.9% is the highest of 6, against a peer median of -13.5%.
  • Total equity amounts to 40.6% of total assets for DXCM, versus a peer median of 52.7%.
DXCM Competitors Peer median
Total Equity for DXCM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MMEDMiniMed Group, Inc. Common StockJul 2026$3.62B ——76.7%
DXCMDexCom, Inc.Jun 2026$2.62B +1.9%+8.8%40.6%
PODDInsulet CorporationJun 2026$1.42B -2.8%+47.1%44.9%
BBNXBeta Bionics, Inc.Mar 2026$271.25M -13.5%+180.7%89.1%
TNDMTandem Diabetes Care, Inc.Mar 2026$132.4M -14.7%-29.3%11.5%
DRIODarioHealth Corp.Mar 2026$62.38M -15.4%-5.3%60.4%
SENSSenseonics Holdings, Inc.Mar 2026$34.34M -2.4%—33.4%
MMEDVMiniMed Group, Inc.—— ———
Peer median (excluding DXCM) $201.82M-13.5%+20.9%52.7%

Competitors are the stored peer set for DXCM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.05B642.3M566.3M606.1M917.7M
Short-term Investments1.68B1.81B2.16B1.97B1.08B
Net Receivables516.6M752.2M987.5M1.03B1.29B
Inventory357.3M306.7M559.6M542.6M629.1M
Other Current Assets27.4M37M64.5M58.3M49.2M
Total Current Assets3.68B3.67B4.43B4.3B4.03B
Property, Plant & Equipment (Net)889.9M1.14B1.18B1.4B1.64B
Goodwill26.5M25.7M25.2M22.8M24.2M
Intangible Assets31.5M173.3M134.5M103.4M70.8M
Long-term Investments019M38.5M119.3M218M
Tax Assets290.5M341.2M419.4M481.2M295.6M
Other Non-current Assets10.5M28.1M36.5M53.7M60.7M
Total Non-current Assets1.25B1.72B1.84B2.18B2.31B
Total Assets4.93B5.39B6.26B6.48B6.34B
Account Payables189.4M237.9M276.4M345.3M344.3M
Short-term Debt0772.6M01.2B0
Tax Payables40.7M44.8M50.1M42.3M0
Deferred Revenue2.1M10.1M18.4M8M7.7M
Other Current Liabilities48.4M47.7M46.4M56.1M54.6M
Total Current Liabilities720.8M1.84B1.56B2.93B2.14B
Long-term Debt1.98B1.2B2.43B1.24B1.24B
Deferred Tax Liabilities5.9M4.9M000
Deferred Revenue (Non-current)16.1M19M7.4M9.5M0
Other Non-current Liabilities11M44.8M59.6M79.9M83.3M
Total Non-current Liabilities2.17B1.42B2.64B1.45B1.45B
Total Liabilities2.89B3.26B4.2B4.38B3.59B
Common Stock400K400K400K400K400K
Retained Earnings138.7M479.9M1.02B1.6B2.43B
Accumulated OCI500K(11.6M)(16.7M)(8M)115M
Other Stockholders Equity00000
Minority Interest00000
Total Equity2.04B2.13B2.07B2.1B2.75B
Total Debt2.16B2.15B2.59B2.59B1.39B
Net Debt1.11B1.5B2.03B1.98B472M

DexCom, Inc.

NASDAQ:DXCM

Intrinsic Alpha fair value

Locked

Current Price

$82.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.